CAS: 23261-20-3; Val-083

该化合物是一种合成甘醇,其化学配方为C6H10O5,主要以其在医疗应用中的作用而著称,特别是在癌症治疗中;它是在水中溶解并表现出甜味的白晶状固体;该化合物是伽丽酯的衍生物,其特点是存在两个可促进其独特化学特性的氢甘基糖单位;Dian hygalactitol作为辐射敏化剂的功能,增强了某些类型肿瘤辐射治疗的功效;其行动机制包括在辐照时形成自由基,这可能导致癌症组织细胞损伤增加;此外,还研究了其潜在的...

结构式图片

上下游产品

CAS号23261-25-8 Galactitol,1,6-... | CAS号608-66-2 卫矛醇 | CAS号51607-75-1 1,5-anhydro-DL-...

合成工艺路线路线简述

    海关参考信息

    专利信息


    专利号:US-11434209-B2
    优先权日:2018-08-21
    标 题 :Method for synthesis of TKX-50 using insensitive intermediate
    发明人:KWON KUK TAE; LEE WOONG HEE; SHIM JEONG SUB; LEE SO JUNG
    权利人:AGENCY DEFENSE DEV
    摘要:The present disclosure relates to a method for synthesis of TKX-50 using an insensitive intermediate, and more specifically, to a method of manufacturing TKX-50 which includes: preparing DCG as a starting material; forming a THP-DAG intermediate from the DCG; and synthesizing TKX-50 through the THP-DAG intermediate.

    专利号:US-8921585-B2
    优先权日:2010-08-18
    标题 :Method of synthesis of substituted hexitols such as dianhydrogalactitol
    发明人:BROWN DENNIS M
    权利人:DEL MAR PHARMACEUTICALS
    摘要:The present invention provides an efficient method of synthesizing and purifying dianhydrohexitols such as dianhydrogalactitol. In general, as applied to dianhydrogalactitol, the method comprises: (1) reacting dulcitol with a concentrated solution of hydrobromic acid at a temperature of about 80° C. to produce dibromogalactitol; (2) reacting the dibromogalactitol with potassium carbonate in t-butanol to produce dianhydrogalactitol; and (3) purifying the dianhydrogalactitol using a slurry of ethyl ether to produce purified dianhydrogalactitol. Another method produces dianhydrogalactitol from dulcitol; this method comprises: (1) reacting dulcitol with a reactant to convert the 1,6-hydroxy groups of dulcitol to an effective leaving group to generate an intermediate; and (2) reacting the intermediate with an inorganic weak base to produce dianhydrogalactitol through an intramolecular S N 2 reaction. Other methods for the synthesis of dianhydrogalactitol from dulcitol are described.

    专利号:US-2022118123-A1
    优先权日:2019-02-22
    标 题 :Combination of ar antagonists and targeted thorium conjugates
    发明人:HAMMER STEFANIE; HAGEMANN URS BEAT; HAENDLER BERNARD; LEJEUNE PASCALE; ZITZMANN-KOLBE SABINE; SCHATZ CHRISTOPH; KARLSSON JENNY
    权利人:BAYER AG; BAYER AS
    摘要:The present invention covers combinations of at least two components, component A and component B, comprising component A being PSMA-TTC, and component B being an antiandrogen selected form AR antagonists such as from cyproterone acetate, bicalutamide, flutamide, nilutamide, enzalutamide, apalutamide, darolutamide or keto-darolutamide, or an AR degrader such as ARV-110, or an ARN-terminal domain binder such as EPI-506, or an antisense oligonucleotide that reduces AR expression such as EZN-4176 or AZD-5312, or an androgen synthesis inhibitor such as abiraterone, particularly abiraterone acetate, seviteronel, galeterone, orteronel or ketoconazole, or a dual AR antagonist and androgen synthesis inhibitor such as ODM-204. Another aspect of the present invention covers the use of such combinations as described herein for the preparation of a medicament for the treatment or prophylaxis of a disease, particularly for the treatment of a hyper-proliferative disease.

    专利号:US-2024382626-A1
    优先权日:2023-05-16
    标题 :Irradiation amenable liposomal dye aggregates and methods of synthesis and use thereof
    发明人:PORTER TYRONE; STERN NOAH; TUNNELL JAMES; SHRESTHA BINITA
    权利人:UNIV TEXAS
    摘要:The present invention provides lipid nanoparticles that are amenable to an irradiation at a wavelength at or above 850 nm, have an absorption peak from about 850 to 1100 nm wavelength, and comprise a high transition temperature lipid and a dye (e.g., a J-aggregate of a dye). In some embodiments, the dye (e.g., J-aggregate of the dye) is encapsulated in the lipid nanoparticle. In various embodiments, the present invention also relates to compositions comprising said lipid nanoparticles and methods of generating said lipid nanoparticles and compositions thereof. The present invention further relates to methods relating to the said lipid nanoparticles for imaging, detection, and treatment of diseases or disorders (e.g., phototherapy) in a subject.

    专利号:CA-2808629-A1
    优先权日:2010-08-18
    标题 :Method of synthesis of substituted hexitols such as dianhydrogalactitol

    专利号:WO-2012024368-A2
    优先权日:2010-08-18
    标题 :Method of synthesis of substituted hexitols such as dianhydrogalactitol

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献


    1: Szende B, Jeney A, Institoris L. The diverse modification of N-butyl-N-(4-hydroxybutyl) nitrosamine induced carcinogenesis in urinary bladder by dibromodulcitol and dianhydrodulcitol. Acta Morphol Hung. 1992;40(1-4):187-93. Chinese.

    合成参考文献


    摘要:Cancer Chemotherapy Reports, Part 1., 56(593), 1972 []
    摘要:National Cancer Institute Screening Program Data Summary, Developmental Therapeutics Program., JAN1986
    摘要:Cancer Treatment Reports., 60(1585), 1976 []
    参考文献:10.1007/bf00173677
    摘要:Weitman S, Carlson L, Pratt CB. New drug development for pediatric oncology. Invest New Drugs. 1996;14(1):1–10. doi: 10.1007/bf00173677.
    摘要:Yang JN, Liu CX, Xu H, Pan QC. Caspases promoted DADAG-induced apoptosis in human leukemia HL-60 cells. Acta Pharmacol Sin. 2002 May;23(5):461–6.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知